eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Original paper

The possible modulatory impact of high-dose statin therapy on carotid intima-media thickness: a preliminary study

Tomasz K. Urbanowicz
1
,
Katarzyna Gabriel
2
,
Ievgen Spasenenko
2
,
Aleksandra Krasińska-Płachta
3
,
Marta Banaszkiewicz
4, 5
,
Krzysztof J. Filipiak
2, 6
,
Zbigniew Krasiński
5
,
Beata Krasińska
2
,
Andrzej Tykarski
2

  1. Cardiac Surgery and Transplantology Department, Poznan University of Medical Sciences, Poznan, Poland
  2. Department of Hypertensiology, Angiology and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
  3. Department of Ophthalmology, Poznan University of Medical Sciences, Poznan, Poland
  4. Chair and Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre, Otwock, Poland
  5. Department of Vascular, Endovascular Surgery, Angiology and Phlebology, Poznan University of Medical Science, Poznan, Poland
  6. Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
Adv Interv Cardiol
DOI: https://doi.org/10.5114/aic.2024.145183
Online publish date: 2024/11/20
Article file
- The possible modulatory.pdf  [0.19 MB]
Get citation
 
 
1. Kabłak-Ziembicka A, Przewłocki T. Clinical significance of carotid intima-media complex and carotid plaque assessment by ultrasound for the prediction of adverse cardiovascular events in primary and secondary care patients. J Clin Med 2021; 10: 4628-53.
2. Bots ML, Evans GW, Tegeler CH, Meijer R. Carotid intima-media thickness measurements: relations with atherosclerosis, risk of cardiovascular disease and application in randomized controlled trials. Chin Med J (Engl) 2016; 129: 215-26.
3. van Bergen En Henegouwen K, Hutten BA, Luirink IK, et al. Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: a systematic review and meta-analysis. J Clin Lipidol 2022; 16: 128-42.
4. Song P, Fang Z, Wang H, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health 2020; 8: e721-9.
5. Razzouk L, Rockman CB, Patel MR, et al. Co-existence of vascular disease in different arterial beds: Peripheral artery disease and carotid artery stenosis--Data from Life Line Screening(®). Atherosclerosis 2015; 241: 687-91.
6. Fu J, Deng Y, Ma Y, et al. National and provincial-level prevalence and risk factors of carotid atherosclerosis in Chinese adults. JAMA Netw Open 2024; 7: e2351225-40.
7. Urbanowicz TK, Skotak K, Lesiak M, et al. Coronary artery culprit lesions progression and ambient temperature exposure – personalised analysis. Adv Interv Cardiol 2024; 20: 139-47.
8. Urbanowicz T, Skotak K, Olasińska-Wiśniewska A, et al. The interplay between dyslipidemia and neighboring developments in coronary artery disease progression: a personalized approach. J Pers Med 2024; 14: 237-51.
9. Premnath SM, Nanda SK, Ray L, Arokiaraj MC. Effect of statins on the inflammatory markers in patients with coronary artery disease. J Lab Physicians 2023; 15: 498-502.
10. Mitkowski P, Witkowski A, Stępińska J, et al. Position of the Polish Cardiac Society on therapeutic targets for LDL cholesterol concentrations in secondary prevention of myocardial infarctions. Kardiol Pol 2023; 81: 818-23.
11. Kadoglou NP, Khattab E, Velidakis N, et al. A new approach of statin therapy in carotid atherosclerosis: targeting indices of plaque vulnerability on the top of lipid-lowering. A narrative review. Kardiol Pol 2022; 80: 880-90.
12. Henriksbo BD, Schertzer JD. Is immunity a mechanism contributing to statin-induced diabetes? Adipocyte 2015; 4: 232-8.
13. Stępień K, Natorska J, Ząbczyk M, et al. High-dose atorvastatin and rosuvastatin reduce neutrophil extracellular traps-related proteins in coronary artery disease: association with prothrombotic state. Pol Arch Intern Med 2024; 134: 16852.
14. Karapostolakis G, Vakaki M, Attilakos A, et al. The effect of long-term atorvastatin therapy on carotid intima-media thickness of children with dyslipidemia. Angiology 2021; 72: 322-31.
15. Effoe VS, Rodriguez CJ, Wagenknecht LE, et al. Carotid intima-media thickness is associated with incident heart failure among middle-aged whites and blacks: the Atherosclerosis Risk in Communities study. J Am Heart Assoc 2014; 3: e000797.
16. Aladin AI, Soliman EZ, Kitzman DW, et al. Comparison of the relation of carotid intima-media thickness with incident heart failure with reduced versus preserved ejection fraction (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2021; 148: 102-9.
17. Sadowski J, Targonski R, Cyganski P, et al. Remodeling of retinal arterioles and carotid arteries in heart failure development-a preliminary study. J Clin Med 2022; 11: 3721.
18. Cuspidi C, Lonati L, Macca G, et al. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected hypertensive population: impact of different echocardiographic and ultrasonographic diagnostic criteria. Blood Press. 2001; 10: 142-149.
19. McDonagh TA, Metra M, Adamo M, et al.; ESC Scientific Document Group. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023; 44: 3627-39.
20. El Jalbout R, Levy E, Pastore Y, et al. Current applications for measuring pediatric intima-media thickness. Pediatr Radiol 2022; 52: 1627-38.
21. Visseren FLJ, Mach F, Smulders YM, et al.; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 2022; 29: 5-115.
22. Montecucco F, Mach F. New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor. Clin Interv Aging 2008; 3: 341-9.
23. Liao M, Liu L, Bai L, et al. Correlation between novel inflammatory markers and carotid atherosclerosis: a retrospective case-control study. PLoS One 2024; 19: e0303869.
24. Lavine K. Identification of inflammatory lipid-associated macrophages in human carotid atherosclerosis. Nat Cardiovasc Res 2023; 2: 604-5.
25. Kelesoglu S, Yilmaz Y, Elcik D, et al. Increased serum systemic immune-inflammation index is independently associated with severity of carotid artery stenosis. Angiology 2023; 74: 790-7.
26. Chlorogiannis DD, Pargaonkar S, Papanagiotou P, et al. Inflammation, anti-inflammatory agents, and the role of colchicine in carotid artery stenosis. Vasa 2024; 53: 4-12.
27. Lv Q, Wang Y, Li Y, et al. Rosuvastatin reverses hypertension-induced changes in the aorta structure and endothelium-dependent relaxation in rats through suppression of apoptosis and inflammation. J Cardiovasc Pharmacol 2020; 75: 584-95.
28. Sánchez-León ME, Loaeza-Reyes KJ, Matias-Cervantes CA, et al. LOX-1 in cardiovascular disease: a comprehensive molecular and clinical review. Int J Mol Sci 2024; 25: 5276-303.
29. Zhang L, Huang FY, Dai SZ, et al. Rosuvastatin attenuates airway inflammation and remodeling in a chronic allergic asthma model through modulation of the AMPKα signaling pathway. PLoS One 2024; 19: e0305863.
30. Hoshi RA, Alotaibi M, Liu Y, et al. One-year effects of high-intensity statin on bioactive lipids: findings from the JUPITER trial. Arterioscler Thromb Vasc Biol 2024; 44: e196-206.
31. Ueland T, Butt N, Lekva T, et al. High dose statin treatment reduces circulating Dickkopf-1 following acute myocardial infarction. Int J Cardiol 2024; 406: 132035.
32. Yin Z, You S, Zhang S, et al. Atorvastatin rescues vascular endothelial injury in hypertension by WWP2-mediated ubiquitination and degradation of ATP5A. Biomed Pharmacother 2023; 166: 115228.
33. Chu T, Huang M, Zhao Z, et al. Atorvastatin reduces accumulation of vascular smooth muscle cells to inhibit intimal hyperplasia via p38 MAPK pathway inhibition in a rat model of vein graft. Arq Bras Cardiol 2020; 115: 630-6.
34. Chen W, Tian T, Wang S, et al. Characteristics of carotid atherosclerosis in elderly patients with type 2 diabetes at different disease course, and the intervention by statins in very elderly patients. J Diabetes Investig 2018; 9: 389-95.
35. Khazaei M, Khosravi M, Mazaheri S, et al. The effect of atorvastatin on the common carotid artery intima-media thickness in patients with ischemic stroke. Acta Clin Croat 2020; 59: 223-6.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.